Presenter: Kevin Spelman, PhD

Original Date: December 3, 2023

The art of using Echinacea has been skewed over the last decade by various claims, extractions and research that puts this medicinal plant in question. We will review clinical guidelines, extractions, research and the main species on the market E. purpurea, E. angustifolia and E. pallida for effective and meaningful outlines in the clinic for the treatment of infections.

Dr. Kevin Spelman is a molecular biologist, phytotherapist and nutrition consultant who has worked with medicinal plants in the field and clinic. As a researcher he has performed clinical trials and immunological investigations, studied plants for brain & ovarian cancer, cannabinoid signaling and chemical analysis. International research has included the analysis of nutrient levels in teenage women in West Africa, working with children with neurological disorders in Central America and investigating antimalarial plant activity in France. As a clinician, he has practiced Ayurvedic medicine, supported by the understanding of the molecular interface between phytonutrients and human cellular networks, for over 3 decades and has delivered over 100 CMEs/CEUs for healthcare providers. Dr. Spelman has been an adjunct assistant professor at Mass College of Pharmacy and Health Sciences, National University of Natural Medicine, Bastyr University & Maryland University of Integrative Health and directs Health, Education & Research, a consulting service for the Natural Products and Cannabis industry which offers services in research, formulations, product development and novel phytochemical applications. He currently holds 3 formulation patents.

1.5 General CEUs approved by OBNM